Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene Hugo description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 2510 to 2559 of 3228 in total 
Value Type: Ranked
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Hugo\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2510\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GRPEL2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
grpe protein homolog 2, mitochondrial precursor (mt-grpe#2). [source:swissprot;acc:q8taa5]\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
234.384\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
234.948\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.00241\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2511\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GRPEL1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
grpe protein homolog 1, mitochondrial precursor (mt-grpe#1) (hmge). [source:swissprot;acc:q9hav7]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2512\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SMARCD2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
swi/snf-related matrix-associated actin-dependent regulator of chromatin d2; rsc6p; mammalian chromatin remodeling complex brg1-associated factor 60b; swp73-like protein; chromatin remodeling complex baf60b subunit; swi/snf complex 60 kda subunit b. [source:refseq;acc:nm\_003077]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2513\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SMARCD3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
swi/snf-related matrix-associated actin-dependent regulator of chromatin d3; rsc6p; mammalian chromatin remodeling complex brg1-associated factor 60c; swp73-like protein; chromatin remodeling complex baf60c subunit; swi/snf complex 60 kda subunit c. [source:refseq;acc:nm\_003078]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2514\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SMARCD1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
swi/snf related, matrix associated, actin dependent regulator of chromatin subfamily d member 1 (swi/snf complex 60 kda subunit) (brg1- associated factor 60a). [source:swissprot;acc:q96gm5]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2515\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DFFB\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
dna fragmentation factor 40 kda subunit (ec 3.-.-.-) (dff-40) (caspase-activated deoxyribonuclease) (caspase-activated dnase) (cad) (caspase-activated nuclease) (cpan). [source:swissprot;acc:o76075]\vspace{3pt}}&\multirow{6}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
215.835\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
216.341\vspace{3pt}}}&\multirow{12}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.00234\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2516\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ADAMTS9\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
adamts-9 precursor (ec 3.4.24.-) (a disintegrin and metalloproteinase with thrombospondin motifs 9) (adam-ts 9) (adam-ts9). [source:swissprot;acc:q9p2n4]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2517\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DFFA\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
dna fragmentation factor alpha subunit (dna fragmentation factor 45 kda subunit) (dff-45) (inhibitor of cad) (icad). [source:swissprot;acc:o00273]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2518\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ANK3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ankyrin 3 (ank-3) (ankyrin g). [source:swissprot;acc:q12955]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2519\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ANK2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ankyrin 2 (brain ankyrin) (ankyrin b) (ankyrin, nonerythroid). [source:swissprot;acc:q01484]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2520\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ARL3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
adp-ribosylation factor-like protein 3. [source:swissprot;acc:p36405]\vspace{3pt}}&&&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
2521\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
nuclear receptor co-repressor/hdac3 complex subunit tblr1 (tbl1- related protein 1). [source:swissprot;acc:q9bzk7]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
201.96\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
201.488\vspace{3pt}}&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
2522\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
UNC119\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
unc-119 protein homolog (retinal protein 4) (hrg4). [source:swissprot;acc:q13432]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
215.835\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
216.341\vspace{3pt}}&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
2523\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
KPNB1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
importin beta-1 subunit (karyopherin beta-1 subunit) (nuclear factor p97) (importin 90). [source:swissprot;acc:q14974]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
201.96\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
201.488\vspace{3pt}}}&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2524\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TBL1X\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
transducin beta-like 1x protein (transducin-beta-like 1, x-linked). [source:swissprot;acc:o60907]\vspace{3pt}}&&&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
2525\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PSMD8\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
26s proteasome non-atpase regulatory subunit 8 (26s proteasome regulatory subunit s14) (p31). [source:swissprot;acc:p48556]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
215.835\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
216.341\vspace{3pt}}&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
2526\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TBL1Y\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
transducin beta-like 1y protein (transducin-beta-like 1, y-linked). [source:swissprot;acc:q9bq87]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
201.96\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
201.488\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2527\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TKTL1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
transketolase-like 1 (ec 2.2.1.1) (transketolase 2) (tk 2) (transketolase related protein). [source:swissprot;acc:p51854]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
209.143\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
208.659\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00232\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2528\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SCRIB\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
scribble. [source:refseq;acc:nm\_015356]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
221.782\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
222.291\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0023\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2529\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
LRRC1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
lap (leucine-rich repeats and pdz) and no pdz protein. [source:refseq;acc:nm\_018214]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
221.776\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
222.283\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00229\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2530\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
proteasome subunit beta type 8 precursor (ec 3.4.25.1) (proteasome component c13) (macropain subunit c13) (multicatalytic endopeptidase complex subunit c13). [source:swissprot;acc:p28062]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
212.464\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
211.99\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00224\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2531\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
APEX2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
apurinic/apyrimidinic endonuclease 2; apurinic/apyrimidinic endonuclease-like 2; apex nuclease-like 2. [source:refseq;acc:nm\_014481]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
216.264\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
215.787\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00221\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2532\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NONO\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
54 kda nuclear rna- and dna-binding protein (p54(nrb)) (p54nrb) (55 kda nuclear protein) (nmt55) (non-pou domain-containing octamer- binding protein) (dna-binding p52/p100 complex, 52 kda subunit). [source:swissprot;acc:q15233]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
190.405\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
190.812\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.00214\vspace{3pt}}}\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
2533\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PSPC1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
paraspeckle protein 1. [source:refseq;acc:nm\_018282]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
190.417\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
190.824\vspace{3pt}}&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
2534\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GPD2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
glycerol-3-phosphate dehydrogenase, mitochondrial precursor (ec 1.1.99.5) (gpd-m) (gpdh-m). [source:swissprot;acc:p43304]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
208\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
207.555\vspace{3pt}}&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
2535\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CBX1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
chromobox protein homolog 1 (heterochromatin protein 1 homolog beta) (hp1 beta) (modifier 1 protein) (m31) (heterochromatin protein p25). [source:swissprot;acc:p23197]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
188.228\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
188.63\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2536\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GGPS1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
geranylgeranyl pyrophosphate synthetase (ggpp synthetase) (ggppsase) (geranylgeranyl diphosphate synthase) [includes: dimethylallyltransferase (ec 2.5.1.1); geranyltranstransferase (ec 2.5.1.10); farnesyltranstransferase (ec 2.5.1.29)]. [source:swissprot;acc:o95749]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
236.51\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
236.008\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00213\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2537\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
VPS45\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
vacuolar protein sorting-associated protein 45 (h-vps45) (hlvps45). [source:swissprot;acc:q9nrw7]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
215.964\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
216.421\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00212\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2538\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SFPQ\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
splicing factor, proline-and glutamine-rich (polypyrimidine tract- binding protein-associated splicing factor) (ptb-associated splicing factor) (psf) (dna-binding p52/p100 complex, 100 kda subunit). [source:swissprot;acc:p23246]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
190.765\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
191.163\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00209\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2539\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
C21orf66\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
gc-rich sequence dna-binding factor homolog. [source:swissprot;acc:q9y5b6]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
217.144\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
216.699\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.00205\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2540\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TLR2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
toll-like receptor 2 precursor (toll/interleukin 1 receptor-like protein 4). [source:swissprot;acc:o60603]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2541\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DARS\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
aspartyl-trna synthetase (ec 6.1.1.12) (aspartate--trna ligase) (asprs). [source:swissprot;acc:p14868]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
194.505\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
194.902\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00204\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2542\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ING4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
p29ing4; candidate tumor suppressor p33 ing1 homolog. [source:refseq;acc:nm\_016162]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.068\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
217.633\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.002\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2543\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
BRPF1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
tubulin tyrosine ligase-like protein hottl (hqp0207). [source:swissprot;acc:q9y4r7]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
224.726\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
225.164\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00195\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2544\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
AMT\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
aminomethyltransferase, mitochondrial precursor (ec 2.1.2.10) (glycine cleavage system t protein) (gcvt). [source:swissprot;acc:p48728]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
212.67\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
212.262\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00192\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2545\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
proteasome subunit beta type 9 precursor (ec 3.4.25.1) (proteasome chain 7) (macropain chain 7) (multicatalytic endopeptidase complex chain 7) (ring12 protein) (low molecular mass protein 2). [source:swissprot;acc:p28065]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
213.494\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
213.088\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00191\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2546\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TAF9B\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
tbp-associated factor 9l; neuronal cell death-related protein; taf9-like rna polymerase ii, tata box binding protein (tbp)-associated factor, 31 kd; neuronal cell death-related gene in neuron-7; transcription associated factor tafii31l; transcription initiation factor iid, 31kd subunit. [source:refseq;acc:nm\_015975]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
197.138\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
197.507\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00187\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2547\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
glycerol kinase, testis specific 2 (ec 2.7.1.30) (atp:glycerol 3- phosphotransferase) (glycerokinase) (gk). [source:swissprot;acc:q14410]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
206.894\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
206.51\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00186\vspace{3pt}}\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
2548\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
glycerol kinase, testis specific 1 (ec 2.7.1.30) (atp:glycerol 3- phosphotransferase) (glycerokinase) (gk). [source:swissprot;acc:q14409]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
206.899\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
206.516\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.00185\vspace{3pt}}}\\\cline{1-1}\cline{3-5}
\parbox{\wcA}{\vspace{3pt}\noindent
2549\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
glycerol kinase (ec 2.7.1.30) (atp:glycerol 3-phosphotransferase) (glycerokinase) (gk). [source:swissprot;acc:p32189]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
206.902\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
206.519\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2550\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
EPN2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
epsin 2 isoform b; eps15 binding protein. [source:refseq;acc:nm\_014964]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.587\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
217.988\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00184\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2551\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
FBP2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
fructose-1,6-bisphosphatase isozyme 2 (ec 3.1.3.11) (d-fructose-1,6- bisphosphate 1-phosphohydrolase) (fbpase). [source:swissprot;acc:o00757]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
209.766\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
210.148\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00182\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2552\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CDY1B\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
testis-specific chromodomain y protein 1. [source:swissprot;acc:q9y6f8]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
193.12\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
193.467\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.0018\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2553\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CDYL\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
chromodomain protein, y chromosome-like isoform a; cdy-like, autosomal; testis-specific chromodomain y-like protein. [source:refseq;acc:nm\_004824]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2554\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CDY2B\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
testis-specific chromodomain protein y protein 2. [source:swissprot;acc:q9y6f7]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2555\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MAT2A\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
s-adenosylmethionine synthetase gamma form (ec 2.5.1.6) (methionine adenosyltransferase) (adomet synthetase) (mat-ii). [source:swissprot;acc:p31153]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
212.953\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
212.572\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00179\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2556\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CDYL2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
chromodomain y-like protein 2. [source:refseq;acc:nm\_152342]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
193.119\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
193.46\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00177\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2557\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
EEF2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
elongation factor 2 (ef-2). [source:swissprot;acc:p13639]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
222.658\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
223.047\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.00175\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2558\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GRM2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
metabotropic glutamate receptor 2 precursor (mglur2). [source:swissprot;acc:q14416]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2559\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
metabotropic glutamate receptor 3 precursor (mglur3). [source:swissprot;acc:q14832]\vspace{3pt}}&&&\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Hugo is the HGNC identifier if it exists

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/